昭衍新药
(603127)
| 流通市值：235.12亿 | | | 总市值：279.51亿 |
| 流通股本：6.30亿 | | | 总股本：7.49亿 |
| 日期 |
超大单净流入 |
大单净流入 |
中单净流入 |
小单净流入 |
| 净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
净额 |
净占比 |
| 2026-04-23 | -896.12万 | -1.16% | -3108.42万 | -4.03% | -1130.32万 | -1.46% | 5134.85万 | 6.65% |
| 2026-04-22 | -890.13万 | -1.16% | -2149.66万 | -2.80% | -3371.83万 | -4.39% | 6411.62万 | 8.35% |
| 2026-04-21 | -2783.06万 | -3.31% | -2733.63万 | -3.25% | -2395.29万 | -2.84% | 7911.98万 | 9.40% |
| 2026-04-20 | -3244.24万 | -3.26% | 4679.09万 | 4.71% | 1406.80万 | 1.42% | -2841.64万 | -2.86% |
| 2026-04-17 | -8004.24万 | -6.72% | -11758.47万 | -9.88% | -1791.45万 | -1.50% | 21554.16万 | 18.10% |
| 2026-04-16 | -54.54万 | -0.04% | 730.63万 | 0.52% | -2003.15万 | -1.43% | 1327.05万 | 0.95% |
| 2026-04-15 | 3397.53万 | 1.58% | 8406.34万 | 3.90% | 5032.50万 | 2.33% | -16836.37万 | -7.81% |
| 2026-04-14 | 3970.64万 | 2.67% | 7470.24万 | 5.02% | -8216.34万 | -5.53% | -3224.55万 | -2.17% |
| 2026-04-13 | 308.43万 | 0.23% | -8338.22万 | -6.10% | -7989.24万 | -5.85% | 16019.03万 | 11.73% |
| 2026-04-10 | 3413.25万 | 2.05% | 808.79万 | 0.49% | 501.24万 | 0.30% | -4723.28万 | -2.83% |